ACT-FASTER, a Prospective Cohort Study Exploring Treatment Patterns with Fulvestrant and Exemestane in Postmenopausal Patients with Advanced Hormone Receptor-Positive Breast Cancer under Real-Life Conditions in Germany

BACKGROUND: Endocrine therapy is recommended for the treatment of postmenopausal women with hormone receptor-positive (HR+) advanced breast cancer (ABC). METHODS: ACT-FASTER was a German prospective non-interventional cohort study in postmenopausal women with HR+ ABC receiving fulvestrant 500 mg as...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Breast Care (Basel)
Autors principals: Maass, Nicolai, Ostermann, Helmut, Possinger, Kurt, Klein, Peter, Tesch, Hans, Mühlenhoff, Lars, Bauerschlag, Dirk
Format: Artigo
Idioma:Inglês
Publicat: S. Karger AG 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6940445/
https://ncbi.nlm.nih.gov/pubmed/31933587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000493882
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars